CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment.

@article{Blennow2005CSFBF,
  title={CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment.},
  author={K Blennow},
  journal={Expert review of molecular diagnostics},
  year={2005},
  volume={5 5},
  pages={661-72}
}
  • K Blennow
  • Published 2005 in Expert review of molecular diagnostics
Early diagnosis of Alzheimer's disease is important in initiating symptomatic treatment with acetylcholine esterase inhibitors, and will be of even greater significance if drugs with a potential to slow down the degenerative process, such as beta-secretase inhibitors and beta-amyloid vaccination, prove to have a clinical effect. During the last decade, research efforts have focused on developing cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease. In this review, the background and… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 44 extracted citations

Similar Papers

Loading similar papers…